A phase II/III randomized trial of two doses of MK-3475 versus docetaxel in previously treated subjects with non-small cell lung cancer

Autores: Herbst, R. S.; Gurpide Ayarra, Luis Alfonso; Surmont, V.; Kim, D. W.; Waqar, S. N.; Herder, J.; Lee, D. H.; Carcereny, E.; Reguart, N.; Wallmark, J.; Ramalingam, S. S.; Langer, C. J.; Lubiniecki, G. M.; Knowles, J.; Zhou, H.; Hanson, M. E.; Baas, P.